Dimensional Fund Advisors
STOK icon

Dimensional Fund Advisors’s Stoke Therapeutics STOK Stock Holding History

Dimensional Fund Advisors’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$24M Sell
924,342
-89,569
-9% -$2.71M ﹤0.01% 1928
2026
Q2 		$33.2M Buy
1,013,911
+23,975
+2% +$769K 0.01% 1806
2026
Q1 		$32.2M Buy
989,936
+162,797
+20% +$5.34M 0.01% 1731
2025
Q4 		$26.3M Buy
827,139
+148,832
+22% +$4.47M 0.01% 1846
2025
Q3 		$15.9M Buy
678,307
+4,423
+0.7% +$75.8K ﹤0.01% 2106
2025
Q2 		$7.65M Buy
673,884
+9,149
+1% +$86.9K ﹤0.01% 2375
2025
Q1 		$4.42M Buy
664,735
+125,835
+23% +$1.17M ﹤0.01% 2531
2024
Q4 		$5.94M Buy
538,900
+273,890
+103% +$3.36M ﹤0.01% 2486
2024
Q3 		$3.26M Buy
265,010
+73,650
+38% +$1.04M ﹤0.01% 2660
2024
Q2 		$2.58M Sell
191,360
-28,405
-13% -$384K ﹤0.01% 2698
2024
Q1 		$2.97M Buy
219,765
+4,471
+2% +$27.1K ﹤0.01% 2692
2023
Q4 		$1.13M Sell
215,294
-43,128
-17% -$184K ﹤0.01% 2905
2023
Q3 		$1.02M Sell
258,422
-81,723
-24% -$537K ﹤0.01% 2924
2023
Q2 		$3.62M Buy
340,145
+46,513
+16% +$495K ﹤0.01% 2622
2023
Q1 		$2.45M Buy
+293,632
New +$2.65M ﹤0.01% 2694
2022
Q3 		$4.35M Buy
338,996
+73,975
+28% +$1.18M ﹤0.01% 2476
2022
Q2 		$3.5M Buy
265,021
+113,361
+75% +$1.72M ﹤0.01% 2560
2022
Q1 		$3.19M Buy
151,660
+79,518
+110% +$1.59M ﹤0.01% 2682
2021
Q4 		$1.73M Buy
72,142
+27,423
+61% +$654K ﹤0.01% 2884
2021
Q3 		$1.14M Sell
44,719
-60,664
-58% -$1.69M ﹤0.01% 3018
2021
Q2 		$3.55M Sell
105,383
-3,440
-3% -$122K ﹤0.01% 2705
2021
Q1 		$4.22M Buy
108,823
+69,010
+173% +$3.93M ﹤0.01% 2633
2020
Q4 		$2.46M Buy
39,813
+32,432
+439% +$1.49M ﹤0.01% 2751
2020
Q3 		$247K Buy
+7,381
New +$211K ﹤0.01% 3181

Other funds holding STOK

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
SYM Financial Corp
SYM Financial Corp Winona Lake, Indiana $1.31B AUM 18.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Moran Wealth Management
Moran Wealth Management Naples, Florida $3.64B AUM 28.63% 1-Year Est. Return

Dimensional Fund Advisors's STOK Position: Q3 2026 in Review

Dimensional Fund Advisors reduced its Stoke Therapeutics (STOK) stake by 8.8% in Q3 2026, selling an estimated $2.71M and leaving 924,342 shares worth $24M. The position accounts for ﹤0.01% of the portfolio, ranked #1928.

Dimensional Fund Advisors first reported a position in STOK in Q3 2020 and has held it in 24 quarters since. The position peaked at $33.2M in Q2 2026. 57 funds tracked by Wall St. Rank hold STOK as of Q3 2026.

  • Dimensional Fund Advisors held 924,342 shares of Stoke Therapeutics worth $24M as of Q3 2026.
  • Dimensional Fund Advisors sold 89,569 Stoke Therapeutics shares in Q3 2026, an estimated $2.71M.
  • Stoke Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #1928 holding.
  • Dimensional Fund Advisors first reported a position in Stoke Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • Dimensional Fund Advisors's Stoke Therapeutics position peaked at $33.2M in Q2 2026.
  • 57 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.